BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Ugur Sahin
, Alexander Muik
, Isabel Vogler
, Evelyna Derhovanessian
, Lena M. Kranz
, Mathias Vormehr
, Jasmin Quandt
, Nicole Bidmon
, Alexander Ulges
, Alina Baum
, Kristen E. Pascal
, Daniel Maurus
, Sebastian Brachtendorf
, Verena Lörks
, Julian Sikorski
, Peter Koch
, Rolf Hilker
, Dirk Becker
, Ann Kathrin Eller
, Jan Grützner
Manuel Tonigold, Carsten Boesler, Corinna Rosenbaum, Ludwig Heesen, Marie Cristine Kühnle, Asaf Poran, Jesse Z. Dong, Ulrich Luxemburger, Alexandra Kemmer-Brück, David Langer, Martin Bexon, Stefanie Bolte, Tania Palanche, Armin Schultz, Sybille Baumann, Azita J. Mahiny, Gábor Boros, Jonas Reinholz, Gábor T. Szabó, Katalin Karikó, Pei Yong Shi, Camila Fontes-Garfias, John L. Perez, Mark Cutler, David Cooper, Christos A. Kyratsous, Philip R. Dormitzer, Kathrin U. Jansen, Özlem Türeci
Dive into the research topics of 'BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans'. Together they form a unique fingerprint.